Hui Li
Heng
a,
Chin Fei
Chee
ab,
Sek Peng
Chin
ab,
Yifan
Ouyang
c,
Hao
Wang
c,
Michael J. C.
Buckle
*a,
Deron R.
Herr
d,
Ian C.
Paterson
e,
Stephen W.
Doughty
f,
Noorsaadah
Abd. Rahman
b and
Lip Yong
Chung
*a
aDepartment of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. E-mail: buckle@um.edu.my; chungly@um.edu.my; Fax: +60 3 79674964; Tel: +60 3 79674959
bDepartment of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
cSchool of Pharmacy, Ningxia Medical University, Yinchuan, 750004, P. R. China
dDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore
eDepartment of Oral Biology and Craniofacial Sciences and Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
fPenang Medical College, 4 Jalan Sepoy Lines, 10450 George Town, Pulau Pinang, Malaysia
First published on 7th March 2018
Correction for ‘Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists’ by Hui Li Heng et al., Med. Chem. Commun., 2018, DOI: 10.1039/c7md00629b.
In addition, there were some errors in the numbering of two of the amino acids in Fig. 4, panels C and D. Please find below the corrected figure, including corrected caption.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2018 |